JULIA QUIGLEY: Open Payments
NPI 1437815586 · ANNVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,118 in 49 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $981 · 2025 $1,118
Food & beverage: $1,118
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $511 |
| PFIZER INC. | 7 | $227 |
| Daiichi Sankyo Inc. | 5 | $110 |
| QOL Medical, LLC | 2 | $56 |
| Madrigal Pharmaceuticals | 1 | $44 |
| Aimmune Therapeutics, Inc. | 1 | $34 |
| Ardelyx, Inc. | 1 | $27 |
| GENZYME CORPORATION | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
Products named: RINVOQ, VELSIPITY, INJECTAFER, XELJANZ, SKYRIZI, Sucraid, REZDIFFRA, VIBERZI.
Industry payments across PA — which companies pay providers there.
